In the News

August 30, 2016

By Sophia Bollag

California lawmakers on Tuesday sent the governor a bill that could help students graduate in four years from California State University schools.

August 30, 2016

By Melanie Mason

State Sen. Ed Hernandez's attempt to push through a drug pricing transparency bill sputtered this year, but the West Covina Democrat still wants his colleagues to weigh in on the latest controversy in the cost of prescription drugs: the surging price of EpiPens. 

Hernandez is introducing a resolution that excoriates the anti-allergy device's manufacturer, Mylan, joining a chorus of federal lawmakers who have accused the company of price-gouging.

August 29, 2016

By Susan Jaffe

Californians with Medicare coverage would no longer be surprised by huge medical bills stemming from “observation care” in hospitals under legislation that state lawmakers approved overwhelmingly last week and sent to Gov. Jerry Brown to sign into law.

August 26, 2016

By Emily Bazar

State Sen. Ed Hernandez and his wife, Diane, are optometrists.

Diane handles some insurance matters for their practice, and she recently told him that a health plan had emailed to request more information: It wanted confirmation that they were both participating providers, he says.

“I didn’t say anything because I was afraid she’d be mad at me,” says Hernandez, D-West Covina.

August 18, 2016

A bill aimed at shedding light on drug costs has been shelved by its author.

On Thursday's Capitol Chat, Capitol Bureau Chief Ben Adler explains why Senator Ed Hernandez decided to stop moving SB 1010 through the Legislature.

SB 1010 was designed to help ensure that healthcare purchasers are notified of price increases for prescription drugs in advance and have information needed to effectively negotiate with drug companies for fair prices.

August 18, 2016

By Melanie Mason and Sophia Bollag

An effort to shed more light on prescription drug prices sputtered in the Legislature on Wednesday, dealing a setback to a burgeoning national movement to rein in healthcare expenses by curbing the cost of medication.

August 17, 2016

By Ben Bradford

A bill that would have required drug companies to notify patients before they increased prices is likely dead at the California Capitol.

The bill’s author, Senator Ed Hernandez, says he will no longer support it, after the Assembly Appropriations committee amended it without his consent.

The amendments make the bill temporary and exempt drug companies from notifying patients if they raise costs less than 25 percent. Hernandez says that allows hefty hikes for $100,000 drugs.

August 17, 2016

By Ana B. Ibarra

After being approved by a key committee last week, a bill that would have required drug companies to justify treatment costs and price hikes was pulled by its author on Wednesday.

August 17, 2016


Legislation meant to discourage sharp increases in drug prices is dead for the year after the author pulled the measure Wednesday, blaming recent amendments that “have made it more difficult for us to accomplish our fundamental goal.”

August 17, 2016

By Sophia Bollag and Melanie Mason

State Sen. Ed Hernández (D-West Covina) is killing his latest effort to shed light on rising pharmaceutical costs after amendments last week weakened the bill, SB 1010.

“I introduced SB 1010 with the intention of shedding light on the reasons precipitating skyrocketing drug prices," Hernández said in a news release. "Unfortunately, recent amendments have made it more difficult for us to accomplish our fundamental goal."